Advertisement

Ads Placeholder
Loading...

Erasca, Inc.

ERASNASDAQ
Healthcare
Biotechnology
$17.81
$1.21(7.29%)
U.S. Market opens in 27h 57m

Erasca, Inc. (ERAS) Stock Overview

Explore Erasca, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap5.5B
P/E Ratio-40.55
EPS (TTM)$-0.44
ROE-0.34%
Fundamental Analysis

AI Price Forecasts

1 Month$14.65
3 Months$19.37
1 Year Target$6.85

ERAS Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Erasca, Inc. (ERAS) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 71.17, suggesting the stock is in an overbought condition. Our forecasting models predict significant price movements, with a 12-month target of $6.85.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -40.55 and a market capitalization of 5.5B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
7.29%
5-Day Change
17.79%
1-Month Change
26.31%
3-Month Change
396.10%
6-Month Change
635.95%
Year-to-Date (YTD) Change
396.10%
1-Year Change
1371.90%
3-Year Change
465.40%
5-Year Change
2.18%
All-Time (Max) Change
2.18%

Contact Information

858 465 6511
10835 Road to the Cure, San Diego, CA, 92121

Company Facts

1,030 Employees
IPO DateJul 16, 2021
CountryUS
Actively Trading

Frequently Asked Questions